After concluding 2024 with strong sales growth, financial strength, and significant pipeline progress, Zai Lab Limited (ZLAB) is now focused on achieving substantial topline growth, with a goal of reaching $2 billion in revenue by 2028.
This commercial-stage, global biopharmaceutical company with a significant presence in both Greater China and the United States has seven marketed products that have been successfully launched in one or more territories across Greater China.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.